Ignite Creation Date:
2025-12-26 @ 10:45 PM
Ignite Modification Date:
2025-12-26 @ 10:45 PM
Study NCT ID:
NCT02604212
Status:
TERMINATED
Last Update Posted:
2019-04-16
First Post:
2015-11-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
Sponsor:
Arrowhead Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-11
First Submit QC Date:
None
Study First Post Date:
2015-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-20
Results First Submit QC Date:
None
Results First Post Date:
2019-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-11
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL